Disorder Name: Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous
Disorder Code: 100209899
Code Range: Not specified
Class Kind: category

Standard Definition:
A pattern of continuous (daily or almost daily) use of dissociative drugs, including ketamine and phencyclidine (PCP), that has caused damage to a person’s physical or mental health or has resulted in behaviour leading to harm to the health of others. The pattern of continuous use of dissociative drugs is evident over a period of at least one month. Harm to health of the individual occurs due to one or more of the following: (1) behaviour related to intoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) a harmful route of administration. Harm to health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behaviour related to dissociative drug intoxication on the part of the person to whom the diagnosis of Harmful pattern of use of dissociative drugs, including ketamine and PCP applies.

Exclusions: Episode of harmful use of dissociative drugs including ketamine or PCP; Dissociative drug dependence including ketamine or PCP

Clinical Description and Diagnostic Guidelines:
Clinical Description:
A pattern of continuous (daily or almost daily) use of dissociative drugs, including ketamine and phencyclidine (PCP), that has caused damage to a person’s physical or mental health or has resulted in behaviour leading to harm to the health of others. The pattern of continuous use of dissociative drugs is evident over a period of at least one month. Harm to health of the individual occurs due to one or more of the following: (1) behaviour related to intoxication; (2) direct or secondary toxic effects on body organs and systems; or (3) a harmful route of administration. Harm to health of others includes any form of physical harm, including trauma, or mental disorder that is directly attributable to behaviour related to dissociative drug intoxication on the part of the person to whom the diagnosis of Harmful pattern of use of dissociative drugs, including ketamine and PCP applies.

Diagnostic Exclusion Criteria:
• Should be differentiated from: Episode of harmful use of dissociative drugs including ketamine or PCP
• Should be differentiated from: Dissociative drug dependence including ketamine or PCP

Diagnostic Guidelines:
• Symptom assessment should be conducted within appropriate time frames
• Consider impact of symptoms on personal, family, social, and occupational functioning
• Evaluate symptom severity and duration
• Rule out symptoms due to substance use, medical conditions, or other psychological disorders
• Recommend use of standardized assessment tools and diagnostic criteria

Treatment Considerations:
• Develop individualized treatment plans
• Consider evidence-based treatment approaches
• Refer to specialist treatment when necessary
• Regular monitoring of treatment progress and plan adjustments

For more detailed clinical guidelines, please refer to official ICD-11 documentation.